The legacy effect of hyperglycaemia in type 2 diabetes - Authors' reply.
Adler AI. et al, (2025), Lancet, 405
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92).
Lin B. et al, (2024), Lancet Diabetes Endocrinol
Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial.
Morrow LM. et al, (2024), J Diabetes, 16
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
Juraschek SP. et al, (2023), JAMA, 330, 1459 - 1471
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Hundertmark MJ. et al, (2023), Circulation, 147, 1654 - 1669
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.
Othonos N. et al, (2023), Nat Commun, 14
Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
Xu S. et al, (2022), Cardiovasc Diabetol, 21
Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials.
Preiss D. et al, (2022), Diabetes Care, 45, e1 - e2
The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized trials
Preiss D. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance.
Xu S. et al, (2021), J Diabetes, 13, 817 - 826
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure.
Hundertmark MJ. et al, (2021), ESC Heart Fail, 8, 2580 - 2590
Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89.
Wamil M. et al, (2021), Diabetes Care, 44, 1877 - 1884
Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88.
Lind M. et al, (2021), Diabetes Care
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysis.
Juraschek SP. et al, (2021), Ann Intern Med, 174, 58 - 68
Refeeding risks in patients requiring intravenous nutrition support: Results of a two-centre, prospective, double-blind, randomised controlled trial
Ambrose T. et al, (2021), Clinical Nutrition ESPEN
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial.
Wamil M. et al, (2020), Diabetes Res Clin Pract, 170